AGTC Applied Genetic Technologies Corporation

3.82
+0.06  (+2%)
Previous Close 3.76
Open 3.79
Price To Book 0.79
Market Cap 69414404
Shares 18,171,310
Volume 17,713
Short Ratio
Av. Daily Volume 82,482

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1/2 six-month data for the dose escalation portion due 4Q 2019.
AAV Gene Therapy
CNGB3 Achromatopsia
Phase 1/2 interim data released December 12, 2018. No signs of clinical activity.
rAAV-hRS1
X-linked retinoschisis (XLRS)
Phase 1/2 dose escalation data due 3Q 2019. Expansion data due 4Q 2019.
AAV-based gene therapy
X-linked Retinitis Pigmentosa (XLRP)

Latest News

  1. Dr. Reddy's (RDY) Q4 Earnings Up Y/Y, Revenues Top Estimates
  2. Edited Transcript of AGTC earnings conference call or presentation 7-May-19 12:00pm GMT
  3. Applied Genetic Technologies (AGTC) Q3 Earnings and Revenues Surpass Estimates
  4. Applied Genetic Technologies: Fiscal 3Q Earnings Snapshot
  5. AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2019
  6. AGTC to Host Third Quarter Financial Results Conference Call and Webcast on May 7, 2019
  7. Applied Genetic Technologies (AGTC) Upgraded to Strong Buy: What Does It Mean for the Stock?
  8. AGTC Announces Reaching Enrollment Milestones in Phase 1/2 Clinical Trials
  9. What Kind Of Investor Owns Most Of Applied Genetic Technologies Corporation (NASDAQ:AGTC)?
  10. Applied Genetic Technologies- An Eye on Optogenetics
  11. Will Applied Genetic Technologies Continue to Surge Higher?
  12. Edited Transcript of AGTC earnings conference call or presentation 7-Feb-19 1:00pm GMT
  13. AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2018
  14. Analysts Estimate Applied Genetic Technologies (AGTC) to Report a Decline in Earnings: What to Look Out for
  15. New Research: Key Drivers of Growth for Hewlett Packard Enterprise, Micron Technology, Cirrus Logic, Applied Genetic Technologies, KemPharm, and Communications — Factors of Influence, Major Initiatives and Sustained Production
  16. Applied Genetic Technologies Corporation (NASDAQ:AGTC): Time For A Financial Health Check
  17. Edited Transcript of AGTC earnings conference call or presentation 8-Nov-18 1:00pm GMT
  18. Applied Genetic Technologies Enters Oversold Territory
  19. Sell-Side Roundup: What's Next For For Applied Genetic After 50% Plunge?